A randomised controlled trial of warfarin versus aspirin for stroke prevention in octogenarians with atrial fibrillation (WASPO)
about
Antithrombotic management of atrial fibrillation in the elderlyAntiplatelets versus anticoagulants for the treatment of cervical artery dissection: Bayesian meta-analysisSystematic review and network meta-analysis of stroke prevention treatments in patients with atrial fibrillation.Efficacy and safety of oral anticoagulants versus aspirin for patients with atrial fibrillation: a meta-analysisUntreated atrial fibrillation in the United Kingdom: Understanding the barriers and treatment optionsDetecting nonvalvular atrial fibrillation and anticoagulant therapy in cardioembolic ischemic stroke.Risk scores and geriatric profile: can they really help us in anticoagulation decision making among older patients suffering from atrial fibrillation?A review of the safety of anticoagulants in older people using the medicines management pathway: weighing the benefits against the risksBleeding risk in randomized controlled trials comparing warfarin and aspirin: a systematic review and meta-analysis.Antithrombotic therapy in cardiac embolism.Use of antithrombotic medications among elderly ischemic stroke patients.Antithrombotic medication for cardioembolic stroke preventionHow to walk the tightrope between harm and protection in selecting the optimal antiplatelet treatment strategy after transcatheter left atrial appendage occlusionStroke prevention: age alone does not rule out warfarin.The case for an elderly targeted stroke management.Prevention of cardioembolic stroke.Antithrombotic therapy for atrial fibrillation: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.Antithrombotic and thrombolytic therapy for ischemic stroke: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.Effectiveness and safety of warfarin and anti-platelet drugs for the primary prevention of stroke in patients with non-valvular atrial fibrillation: a meta-analysis.Anticoagulation for stroke prevention in elderly patients with atrial fibrillation: risk-benefit ratio remains highly favorablePreventing stroke in atrial fibrillation patients - clinical utility of oral anticoagulants.Association between atrial fibrillation, anticoagulation, risk of cerebrovascular events and multimorbidity in general practice: a registry-based studyThromboprophylaxis in atrial fibrillation and association with cognitive decline: systematic review.Exploratory Network Meta Regression Analysis of Stroke Prevention in Atrial Fibrillation Fails to Identify Any Interactions with Treatment Effect.Bleeding risk of antiplatelet drugs compared with oral anticoagulants in older patients with atrial fibrillation: a systematic review and meta-analysis.Stroke prevention with oral anticoagulation in older people with atrial fibrillation - a pragmatic approach.Recent Atrial Fibrillation Guidelines - Looking at Both Sides of the Atlantic.Thromboprophylaxis of elderly patients with AF in the UK: an analysis using the General Practice Research Database (GPRD) 2000-2009Novel oral anticoagulants for stroke prevention in atrial fibrillation: a focus on the older patientAge as a Risk Factor for Stroke in Atrial Fibrillation Patients: Implications in Thromboprophylaxis in the Era of Novel Oral Anticoagulants.New Stroke Prophylaxis Options in Atrial Fibrillation Patients.Antithrombotic therapy - predictor of early and long-term bleeding complications after transcatheter aortic valve implantation.Secondary prevention of stroke.Stroke prevention in atrial fibrillation patients.Atrial fibrillation in the aging heart: pharmacological therapy and catheter ablation in the elderly.Prediction of stroke risk in atrial fibrillation, prevention of stroke in atrial fibrillation, and the impact of long-term monitoring for detecting atrial fibrillation.Can we predict stroke in atrial fibrillation?Antithrombotic therapy for stroke prevention in atrial fibrillation and mechanical heart valves.The CHADS₂versus the new CHA2DS2-VASc scoring systems for guiding antithrombotic treatment of patients with atrial fibrillation: review of the literature and recommendations for use.The impact of antiplatelet and anticoagulant therapies on gastrointestinal symptoms in patients with atrial fibrillation: a systematic review.
P2860
Q26827113-FAF0C2BE-D2CA-4C31-9915-FBAE2427A84EQ27025147-55AC04A8-AEEB-42D6-BFBC-A09101A7F8A6Q27337981-88BDC6A8-7D97-42C3-826E-A0680C8D779FQ28081598-DA909616-673C-41DF-B023-6BDBAD4F1B2FQ28081837-C34AB49B-D619-4F94-80A7-B4FB2D0A4841Q30249817-36EE1CB2-50DE-44E4-AB63-1F957AB52FA3Q33927278-80F64BBB-199A-4CD6-9DEB-46AD7DD309C2Q33949244-D5216548-11D0-4B1A-B008-D4F0C5C02CCAQ34132273-D81978BD-9767-45B5-8A16-AD6C92BE1457Q34362901-46FF695E-B88E-4365-BE7F-DC262CA6F31DQ34776709-2C660CE8-6B12-4CF0-8A50-004C97B18ADAQ35142419-980FAF49-4127-4201-A131-92F2A708D735Q35214488-F543B970-3A20-4259-B4EF-2BD6FCCCBA27Q35246455-081FF7A4-2B79-4D97-B2D2-82DE4CD25AC3Q35641960-E790FEE3-A1D6-492C-846E-1184B38566F3Q35648111-3711B0F0-9FC6-44F7-B27B-755EA41FD96FQ35752573-61C55827-2784-4A9F-851B-B1A02FE63E2EQ35752603-78ECC40D-FE58-4464-BCE4-AEB5F33175F2Q35756360-C52C9592-629F-48B0-9289-FBC0BBA47FDDQ35865147-735263E9-9A92-43EE-865E-9ED9D76B82D2Q35938914-AD556888-04B2-4292-A655-5DA6E66166BAQ35972161-6E83FC68-DCB6-4C31-8D5F-859A1D7DA173Q36096697-24F3438D-6E6D-408A-84E9-53E8877C6DDAQ36112764-84668F08-B733-44CB-B93E-E00949ACE38DQ36341724-47CC5146-2CCB-40DD-980D-6F3170169C57Q36409072-A3EB80C7-5555-474F-B3F0-E210FFA8737FQ36461724-C70B773C-98F7-4EBB-9797-452FA39535E5Q36550795-CD00F4F6-8DC3-4ED0-AD71-F72A3A88E2E6Q36723401-3C22A4CE-E68E-4456-A39E-7F99FF071CB5Q37495783-C474FC5B-7D9A-4283-BCFA-9AD88F42A2D7Q37495909-12BB4F84-F984-437A-897D-4F39EEB2AC8FQ37517942-0690D713-6CEF-4D25-92B2-6035911BD2ECQ37599872-A56F89B2-F51D-46BD-B984-B6686AF07F91Q37780750-3D998236-E3AA-4940-8167-2920B394BF3EQ37882717-0D72553F-2F40-4FFE-AE5A-3EF8F0EA3E75Q37885792-F09512EF-656C-44D3-A141-DA0FC623E16DQ37975986-DE20CE8D-0AF4-4771-9105-FEC57914C16BQ37990454-C01E9B8C-600E-468B-9AE8-F5EA14C03874Q37990851-39F05CC5-D5F5-4E15-A2C3-985667BB0AD7Q38038960-F6DDAC64-8C72-4820-9210-7F965C7B5106
P2860
A randomised controlled trial of warfarin versus aspirin for stroke prevention in octogenarians with atrial fibrillation (WASPO)
description
2007 nî lūn-bûn
@nan
2007 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի մարտին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
A randomised controlled trial ...... th atrial fibrillation (WASPO)
@ast
A randomised controlled trial ...... th atrial fibrillation (WASPO)
@en
A randomised controlled trial ...... th atrial fibrillation (WASPO)
@nl
type
label
A randomised controlled trial ...... th atrial fibrillation (WASPO)
@ast
A randomised controlled trial ...... th atrial fibrillation (WASPO)
@en
A randomised controlled trial ...... th atrial fibrillation (WASPO)
@nl
prefLabel
A randomised controlled trial ...... th atrial fibrillation (WASPO)
@ast
A randomised controlled trial ...... th atrial fibrillation (WASPO)
@en
A randomised controlled trial ...... th atrial fibrillation (WASPO)
@nl
P2093
P3181
P356
P1433
P1476
A randomised controlled trial ...... th atrial fibrillation (WASPO)
@en
P2093
Kevin S Channer
Nicolette Morgan
Robin Portner
Tom Downes
Wilf W Yeo
P3181
P356
10.1093/AGEING/AFL129
P407
P577
2007-03-01T00:00:00Z